Zycoxia P 60mg/325mg Tablet is a combination analgesic and anti-inflammatory medication containing Etoricoxib 60mg and Paracetamol 325mg. Etoricoxib is a selective COX-2 inhibitor that provides effective relief from pain and inflammation by specifically targeting the cyclooxygenase-2 enzyme, thereby reducing the synthesis of pro-inflammatory prostaglandins. Paracetamol, a widely used analgesic and antipyretic agent, acts centrally to alleviate pain and reduce fever through inhibition of prostaglandin synthesis in the central nervous system. The synergistic effect of these two active ingredients makes Zycoxia P suitable for managing acute and chronic musculoskeletal conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and postoperative pain. It offers the advantage of potent anti-inflammatory action with a reduced risk of gastrointestinal side effects commonly associated with non-selective NSAIDs, due to the selective inhibition of COX-2 by Etoricoxib. Paracetamol complements this by providing additional analgesic efficacy without significant anti-inflammatory activity. Zycoxia P should be used under medical supervision, with caution advised in patients with hepatic or renal impairment, cardiovascular disorders, or a history of gastrointestinal bleeding. The dosage and duration of therapy must be individualized based on clinical response and tolerability.